Many patients taking semaglutide for diabetes or weight management wonder whether they can safely receive their annual flu shot
Starting at 0.25 mg and gradually increasing to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg gives your GLP-1 receptors time to adjust

What makes us different: 6+ years NHS experience Weve delivered weight-loss services to over 250,000 NHS patients since 2017 Registered healthcare professionals Get support 5 days a week from UK-registered dietitians and nutritionists Proven results NHS England published our outcomes in the British Medical Journal showing 6.2kg average weight loss at 12 months on our non-medication programme 3 Guaranteed medication supply We cap weekly enrolments to ensure consistent access Comprehensive programme Medication plus behavioural psychology, nutrition education, and lifestyle coaching Our medication-supported programmes Mounjaro Programme Weight loss potential: 20-25% of body weight 4 Monthly cost: Costs to be confirmed in October (including medication, coaching, and app) How it works: Tirzepatide mimics two hormones (GLP-1 and GIP) to reduce appetite and improve blood sugar control Wegovy Programme Weight loss potential: 15-20% of body weight 2 Monthly cost: 149-249, depending on the dose (50 off first month) How it works: Semaglutide mimics GLP-1 hormone to reduce hunger and increase feelings of fullness Both programmes include: Prescription medication delivered monthly Smart weighing scales and a hardback recipe book Daily habit-change content through our award-winning app Personal health coach (registered dietitian/nutritionist) Peer support groups Not a magic pill building habits for life Weight-loss medications are effective at reducing appetite, but research shows that without lifestyle changes, weight regain is common after stopping medication 5

[2] In this article, well walk through why some patients are choosing to switch from Ozempic to Rybelsus for weight loss, what patients can expect from Rybelsus oral semaglutide, and Rybelsus weight loss stories from clinical trials
Weight loss from GLP-1s may improve fertility, especially in women with PCOS (Polycystic Ovary Syndrome), increasing the chance of unplanned conception